WEST BRIDGEWATER, Mass.--(BUSINESS WIRE)--Pressure BioSciences, Inc. (NASDAQ: PBIO) today announced that its Board of Directors has authorized the Company to repurchase up to $500,000 of its outstanding common stock on the open market or in privately negotiated transactions. The timing and amount of share repurchases, if any, will depend on a number of factors, including market and business conditions. The repurchases may be commenced or suspended at any time without prior notice and without further announcement. The Company also announced that pursuant to this authorization it purchased 106,600 shares of its common stock at $2.88 per share from Kyowa Medex Company Ltd., the Japanese distributor of the Company’s legacy business Boston Biomedica, Inc.
